Showing 1-5 of 60 :
OM1 Contributes to Alzheimer’s Disease Research With New PremiOM Dataset of Over 1 Million Patients

Read the full press release >> July 30, 2024 09:00 AM Eastern Daylight Time BOSTON–(BUSINESS WIRE)–OM1, the leader in real-world insights synthesis and evidence generation for life sciences supporting population and personalized data insights, evidence generation through advanced validated AI platforms, big deep clinical data, registries, and globally recognized thought leadership today announced the new[…]

How can Life Science Technology Providers Support the Pharmaceutical Industry in the Transition Toward More Digitally Connected Operations?

June 24, 2024 Pharma’s Almanac Read the full article >> Rich Gliklich, M.D., Chief Executive Officer and founder, OM1 One impactful way will be through platforms that enable data and study automation. In recent remarks, FDA Commissioner Dr. Robert Califf argued that there is tremendous opportunity to simplify and digitize data collection to create more pragmatic[…]

OM1, a Pioneer in Patient Registries, Launches Its Registries Center of Excellence

With a commitment to advancing innovation in patient registries from inception through implementation, the Registries CoE represents a pivotal step toward addressing critical gaps in clinical research June 13, 2024 09:00 AM Eastern Daylight Time Business Wire Read the full press release >> BOSTON–(BUSINESS WIRE)–OM1, the leader in delivering first-in-class RWE technological advancements and AI-powered[…]

Joseph Zabinski, PhD, MEM: Navigating the Future of AI in Skin Cancer Detection

June 3, 2024 Dermatology Times Read the full article >> May recently concluded Melanoma and Skin Cancer Awareness Month, however, the importance of sun protection and early detection doesn’t end with May. Artificial intelligence (AI) continues to be a conversation in dermatology, especially concerning skin cancer detection. To better understand how certain AI platforms can[…]

1 2 3 … 12